Addendum to guidelines on the investigation and management of venous thrombosis at unusual sites (Br. J. Haematol. 2012;159:28–38): Use of Direct Oral Anticoagulants
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18189
Abstract: Currently Direct Oral Anticoagulants (DOACs) are licensed for treatment of deepvein thrombosis (DVT) and pulmonary embolism (PE) whereas warfarin is licensed for all venous thrombosis (VTE). Warfarin, with lowmolecularweight heparin (LMWH) during the acute initial… read more here.
Keywords: thrombosis; venous thrombosis; unusual sites; direct oral ... See more keywords